Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

Vivisol buy of Air Liquide Healthcare business consulted on by UK CMA

11 August 2026 · By · Wire by Fusion42

Published

11 August 2026

Topic

regulatory

◆ Sectors

Health

◆ Geography

United Kingdom

◆ Source

Read at mlex.com →

◆ Verified

Fusion42 · 23 August 2026 · Fusion42 review

The UK Competition and Markets Authority (CMA) is consulting on Vivisol's acquisition of the Air Liquide Healthcare business, signalling potential regulatory scrutiny on the deal impacting healthcare equipment markets.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You face a narrowed window to influence the UK regulatory review of your healthcare merger. Acting fast to address CMA concerns could clear your path to market consolidation.

◆ Coverage

1 source · 11 Aug 2026

◆ Related on Wire

◆ Topics

Healthcmamerger-reviewhealthcareregulatory-approvaluk